We generated an mTOR-driven HCC mouse model, by liver-specific deletion of the tumor suppressors Pten and Tsc1 [2, 3], to investigate the molecular and cellular mechanisms of mTOR-driven tumorgenicity. This evidence concerns the gene TSC1 and hepatocellular carcinoma.